Compare DRTS & ERII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRTS | ERII |
|---|---|---|
| Founded | 2015 | 1992 |
| Country | Israel | United States |
| Employees | 121 | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 641.6M | 595.9M |
| IPO Year | N/A | 2008 |
| Metric | DRTS | ERII |
|---|---|---|
| Price | $7.52 | $11.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $8.67 | ★ $17.07 |
| AVG Volume (30 Days) | 330.6K | ★ 723.1K |
| Earning Date | 05-18-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 5.00 |
| EPS | N/A | ★ 0.42 |
| Revenue | N/A | ★ $134,987,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $699.98 | $20.55 |
| P/E Ratio | ★ N/A | $26.21 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.59 | $9.35 |
| 52 Week High | $8.80 | $18.31 |
| Indicator | DRTS | ERII |
|---|---|---|
| Relative Strength Index (RSI) | 48.11 | 52.33 |
| Support Level | $6.47 | $9.47 |
| Resistance Level | $7.75 | $11.54 |
| Average True Range (ATR) | 0.56 | 0.39 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 19.00 | 64.66 |
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Energy Recovery Inc designs and manufactures energy-saving technologies. The firm uses its proprietary pressure exchanger technology to help customers in multiple industries improve their operations and lower their emissions. Using its proprietary technology, it offers energy recovery devices, including pressure exchangers, pumps, and turbochargers, mainly used for seawater desalination and wastewater treatment. Additionally, the company is involved in the development of emerging technologies, such as the PX G1300 used in industrial and commercial refrigeration applications. The firm's reportable operating segments are: Water, which generates maximum revenue, and Emerging Technologies. Geographically, it generates maximum revenue from the Middle East, and the rest from other markets.